Structure–Activity Relationship Studies toward the Discovery of Selective Apelin Receptor Agonists
Jean‐François Margathe, Xavier Iturrioz, Rodrigo Alvear‐Perez et al. · Journal of Medicinal Chemistry · 2014
Apelin is the endogenous ligand for the previously orphaned G protein-coupled receptor APJ. Apelin and its receptor are widely distributed in the brain, heart, and vasculature, and are emerging as an important regulator of body fluid homeostasis and cardiovascular functions. To further progress in the pharmacology and the physiological role of the apelin receptor, the development of small, bioavailable agonists and antagonists of the apelin receptor, is crucial. In this context, E339-3D6 (1) was described as the first nonpeptidic apelin receptor agonist. We show here that 1 is actually a mixture of polymethylated species, and we describe an alternative and versatile solid-phase approach that allows access to highly pure 27, the major component of 1. This approach was also applied to prepare a series of derivatives in order to identify the crucial structural determinants required for the ligand to maintain its affinity for the apelin receptor as well as its capacity to promote apelin receptor signaling and internalization. The study of the structure-activity relationships led to the identification of ligands 19, 21, and 38, which display an increased affinity compared to that of 27. The latter and 19 behave as full agonists with regard to cAMP production and apelin receptor internalization, whereas 21 is a biased agonist toward cAMP production. Interestingly, the three ligands display a much higher stability in mouse plasma (T1/2 > 10 h) than the endogenous apelin-17 peptide 2 (T1/2 < 4 min).
Cited by 32 works. doi:10.1021/jm401789v
Authors
- Jean‐François Margathe
- Xavier Iturrioz
- Rodrigo Alvear‐Perez
- Claire MARSOL
- Stéphanie Riché
- Hadjila Chabane
- Nassera Tounsi
- Maxime Kuhry
- Denis Heissler
- Marcel Hibert
- Catherine Llorens‐Cortés
- Dominique Bonnet
References
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor
- A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11
- Characterization of Apelin, the Ligand for the APJ Receptor
- The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
- Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility
- Apelin, a Newly Identified Adipokine Up-Regulated by Insulin and Obesity
- Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum
- Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues
- Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain
- Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin